Navin Parwani

Navin Parwani, M.S is a seasoned executive with over 20 years of experience in Quality Assurance and Regulatory Compliance in the Pharmaceutical, Biotechnology and Medical Device fields. He is an experienced professional with extensive experience in drug discovery & development and has implemented GxP compliance for discovery, clinical and commercial-stage products. Before joining the Ikena team, Navin served as Head of Quality at Q32 Bio and at TARIS Biomedical. At TARIS, he was instrumental in providing quality and regulatory leadership leading to the company’s acquisition by Janssen in 2017. He also served as Head of Quality and Regulatory Affairs for Akoya Biosciences and supported its transition from a start-up to publicly listed company. Navin also has significant experience leading FDA and global regulatory body inspections and audits and responding to FDA communications resulting in successful remediation. He holds an M.S degree from Rutgers University.